학술논문
Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial
Document Type
Article
Author
Source
In: Clinical Cardiology . (Clinical Cardiology, September 2018, 41(9):1117-1122)
Subject
Language
English
ISSN
19328737
01609289
01609289